GARFIELD HEIGHTS, Ohio--(BUSINESS WIRE)--AxioMed® Spine Corporation (www.axiomed.com) announces the commercial introduction of its Freedom® Cervical Disc in Europe with a successful implantation in Switzerland. The Freedom Cervical Disc received CE Mark in 2012. AxioMed will also conduct a multi-center Freedom Cervical Disc study as a post-market assessment of the total disc replacement device for the treatment of cervical degenerative disc disease. The study’s clinical results are expected to be used in support of a future Investigational Device Exemption (IDE) application to the U.S. FDA and to support regulatory approval in other markets outside of the EU.
